News & Knowledge
Relevant news
Our IP Blog
ABG IP gives a presentation on intellectual property to translators and interpreters from European institutions
“The importance of translations in the patent system and in other types of industrial property” was the title chosen for the online presentation given by
Online infringement and registered trademarks: critical implementation of online monitoring software
Nowadays, it is very uncommon to have trademark infringement legal proceedings that do not dispute actions through electronic means as one of the infringing acts.
Adventia Pharma: a laboratory dedicated to improving patient nutrition
“Let food be thy medicine, and let medicine be thy food”, said Hippocrates way back in the fifth century BC; nevertheless, it wasn’t until the
Our trademarks department among the best in Spain according to WTR
The Trademarks Department of ABG Intellectual Property and our advisers, Christine Weimann and Inés Cantero, have been selected in the eleventh edition of WTR 1000
Companies with industrial property rights: higher revenue, more employees and higher wages
163% more employees, with 19% higher wages and 20% more revenue per employee. These are the advantages of companies with industrial property rights (patents, trademarks
The Patent Office of the Cooperation Council of the Gulf will not accept new applications
On 5 January 2021, the Supreme Council of the Cooperation Council for the Arab States of the Gulf publicly announced its decision to stop accepting
Impact of Brexit on industrial property rights
LAST UPDATE: 22 DECEMBER 2020 IMPORTANT UPDATE: According to the ratified withdrawal agreement between the EU and the United Kingdom, Union law will continue to
European patent: protection in 45 countries with a single application
Last Update: European patent applications are the speciality of ABG Intellectual Property. In fact, the members of our team include 19 qualified European patent attorneys,
Exclusivity rights for pharmaceutical products. A European perspective
What makes pharmaceutical products special? Pharmaceutical products can normally not be placed into the market unless an approval has been obtained from the medicinal products’s
Prous Institute for Biomedical Research: driving biomedical research in fragile X syndrome and other areas of the central nervous system
Biomedical research has never before been bestowed with such a promising future. The combination of science and technology has expanded the horizon of therapeutic innovation
ABG IP brings Intellectual Property to the largest international event in the nutraceutical industry
Juan Arias, co-founder of ABG Intellectual Property, talked about “Securing Industrial and Intellectual Property protection and avoiding infringement”, which he presented in September in the
Utility models in Spain – Part 2
As a continuation of our article Utility Model – Part 1, which was published recently, we address below some additional aspects related to this modality
